VEGFR-3 fusion proteins

Forskningsoutput: Patent

Sammanfattning

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
Originalspråkengelska
Utgivningsår9 sep 2008
StatusPublicerad - 9 sep 2008
MoE-publikationstypH1 Beviljat patent

Citera det här